The University of Chicago Header Logo

Connection

Dezheng Huo to Injections, Subcutaneous

This is a "connection" page, showing publications Dezheng Huo has written about Injections, Subcutaneous.
Connection Strength

0.060
  1. A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis. Blood Adv. 2024 Nov 26; 8(22):5735-5743.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.